With reference to the amendment to Environment Impact Assessment (EIA) Notification 2006, consider the following statements:
1. All projects or activities in respect of bulk drugs and intermediates, manufactured for addressing various ailments, have been re-categorized from the existing Category ‘A’ to ‘B2’ category.
2. Projects falling under Category B2 are not exempted from requirement of collection of Base line data, EIA Studies and public consultation.
Which of the statements given above is/are correct?